Loading...
Gut microbiome and CAR-T therapy
Considerable progress has been made in cancer therapeutics recently with targeted strategies that are efficacious and less toxic. Immunotherapy and chimeric antigen receptor (CAR) T-cells are increasingly being evaluated in a variety of tumors in the relapsed/refractory as well as frontline disease...
Saved in:
| Published in: | Exp Hematol Oncol |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
BioMed Central
2019
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6862813/ https://ncbi.nlm.nih.gov/pubmed/31827982 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40164-019-0155-8 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|